Tim Wright, Editor09.09.20
This time of the year we here at Contract Pharma are usually in the final frantic phases of putting together our annual Conference and Tabletop Exhibition. Obviously, COVID-19 has stopped that from happening.
However, in place of the in-person event, we’ve launched the Contract Pharma Conference Web Series. Beginning September 23 at 1 pm EST, we will host a series of 10 webinar sessions spread out over the course of 3 weeks. The speakers that would have talked at the New Brunswick, NJ, meeting will broadcast their sessions live via webinar. And, many of the industry’s leading contract service providers will have a presence during the broadcasts through our Sponsor Showcase.
While nothing can beat in-person face-to-face interaction, the digital format does allow us to open up to a much wider audience. If you’ve never come to our event, now, you can simply register and login to attend wherever you are.
The impact of COVID-19 will be a major topic of discussion throughout the sessions. Ben Locwin, International COVID-19 Advisor, Science & Public Health Task Force Member, and regular Contract Pharma contributor, will discuss the genesis of the pandemic, what it’s taught us and what we can do better next time, because there is going to be a next time.
Vanessa Brill and Vincent Colicchio, two VPs at Dr. Reddy’s Laboratories will talk about their strategies for maintaining critical drug supply during the pandemic.
From the investment firm Jefferies, Dave Windley will highlight the opportunities the COVID-19 crisis has created in the contract development and manufacturing market.
FDA expert Ricki Chase from Lachman Consultants will provide an overview of how FDA has responded to the COVID-19 pandemic in both regulatory and compliance oversight.
Addressing the impact of COVID-19 on bioprocessing facilities and suppliers will be Eric Langer from BioPlan Associates and John Avellanet from Cerulean Associates will talk about data integrity trends in the new era of remote inspections.
In addition to these COVID-19-themed talks we’ll also get a legal perspective on quality agreements; hear about oral solid dose quality and production trends; learn about the keys to accelerating early to mid-phase drug development; and explore how to meet current and future DSCSA requirements.
To get the full line-up, speaker details and learn about the event Sponsors, visit www.webseries.contractpharma.com.
As a bonus, at the end of each session we will have a random drawing for one attendee to receive a $500 gift card. You must be online during the session to be eligible.
So, after you’re done reading this be sure to visit here to get registered. We look forward to your attendance!
Tim Wright, Editor
twright@rodmanmedia.com
However, in place of the in-person event, we’ve launched the Contract Pharma Conference Web Series. Beginning September 23 at 1 pm EST, we will host a series of 10 webinar sessions spread out over the course of 3 weeks. The speakers that would have talked at the New Brunswick, NJ, meeting will broadcast their sessions live via webinar. And, many of the industry’s leading contract service providers will have a presence during the broadcasts through our Sponsor Showcase.
While nothing can beat in-person face-to-face interaction, the digital format does allow us to open up to a much wider audience. If you’ve never come to our event, now, you can simply register and login to attend wherever you are.
The impact of COVID-19 will be a major topic of discussion throughout the sessions. Ben Locwin, International COVID-19 Advisor, Science & Public Health Task Force Member, and regular Contract Pharma contributor, will discuss the genesis of the pandemic, what it’s taught us and what we can do better next time, because there is going to be a next time.
Vanessa Brill and Vincent Colicchio, two VPs at Dr. Reddy’s Laboratories will talk about their strategies for maintaining critical drug supply during the pandemic.
From the investment firm Jefferies, Dave Windley will highlight the opportunities the COVID-19 crisis has created in the contract development and manufacturing market.
FDA expert Ricki Chase from Lachman Consultants will provide an overview of how FDA has responded to the COVID-19 pandemic in both regulatory and compliance oversight.
Addressing the impact of COVID-19 on bioprocessing facilities and suppliers will be Eric Langer from BioPlan Associates and John Avellanet from Cerulean Associates will talk about data integrity trends in the new era of remote inspections.
In addition to these COVID-19-themed talks we’ll also get a legal perspective on quality agreements; hear about oral solid dose quality and production trends; learn about the keys to accelerating early to mid-phase drug development; and explore how to meet current and future DSCSA requirements.
To get the full line-up, speaker details and learn about the event Sponsors, visit www.webseries.contractpharma.com.
As a bonus, at the end of each session we will have a random drawing for one attendee to receive a $500 gift card. You must be online during the session to be eligible.
So, after you’re done reading this be sure to visit here to get registered. We look forward to your attendance!
Tim Wright, Editor
twright@rodmanmedia.com
